The deal follows an earlier settlement appealed by 8 states and DC. They agreed to sign on after the Sacklers kicked in more money and accepted other terms.
FOX 43 York's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Names this update
Purdue Pharma, US states agree to new opioid settlement
The deal follows an earlier settlement appealed by 8 states and DC. They agreed to sign on after the Sacklers kicked in more money and accepted other terms.
Members of the powerful Sackler family who oversee Purdue Pharma, maker of highly addictive OxyContin, struck a deal with state attorneys general for $6 billion to settle widespread litigation over the family’s role in perpetuating the opioid epidemic.
THURSDAY, March 3, 2022 (HealthDay News) -- A deal has been reached between members of the Sackler family and their company, Purdue Pharma, to settle thousands of lawsuits over their
The agreement brought holdout states on board, and would settle thousands of lawsuits over the company’s and family’s roles in the opioid epidemic. The Sacklers agreed to pay an extra billion dollars.
Purdue Pharma and the Sackler families reached a settlement with a group of states this week that would require the Sacklers to pay out as much as $6 billion to states, individual claimants and opioid crisis abatement, if approved by a federal bankruptcy court judge.
OxyContin maker Purdue Pharma reached a settlement Thursday over its role in the nation's deadly opioid crisis that includes U.S. states and thousands of local governments, with the Sackler family members who own the company boosting their cash contribution to as much as $6 billion.
OxyContin maker Purdue Pharma reached a settlement Thursday over its role in the nation's deadly opioid crisis that includes 48 U.S. states and thousands of local governments, with the Sackler family members who own the company boosting their cash contribution to as much as $6 billion.
Some criticize settlement, which leaves amount to go to victims of addictive OxyContin unchanged while shielding family from further attempts to make them pay for crisis
THURSDAY, March 3, 2022 (HealthDay News) -- A deal has been reached between members of the Sackler family and their company, Purdue Pharma, to settle thousands of lawsuits over their
Members of the Sackler family who own Purdue Pharma LP and grew wealthy from sales of OxyContin agreed to pay up to $6 billion to settle lawsuits accusing them of helping fuel the opioid-addiction epidemic, earning the unanimous support of state attorneys general to resolve the family’s liability an…
OxyContin maker Purdue Pharma has agreed Thursday to pay up to $6 billion to settle a lawsuit for its role in the opioid crisis. The owners issued a statement of regret for the first time, leaving victims’ families conflicted but hopeful.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Purdue Pharma, US states agree to new opioid settlement | Since Then
